Compounded preparations are dispensed only on a doctor’s prescription.

Short answer: Ashwagandha can be prescribed as a capsule or an oral liquid. Trials and meta-analyses report stress and anxiety benefits, but a 2022 meta-analysis rated the certainty of that evidence as low (PMID 36017529). The cited evidence does not compare the two forms, so the choice is the prescriber’s.

Slices of fresh ashwagandha root and a glass of water on a wooden tray by a window

Why the form question comes up

A patient who wants an ashwagandha preparation for stress and anxiety needs a form as well as a dose. The active is the same in either form. What changes is how the dose is taken and measured, and how the prescriber specifies it.

What the evidence shows

Systematic reviews

A 2022 systematic review and meta-analysis of randomised controlled trials included 12 studies with 1,002 participants and reported a beneficial effect on stress and anxiety following ashwagandha supplementation compared with placebo. The authors also state that the certainty of the evidence was low for both outcomes (PMID 36017529). They call for further high-quality studies to firmly establish clinical efficacy.

Randomised trial with a capsule dose

A 60-day randomised, double-blind, placebo-controlled Phase III trial enrolled 60 patients with stress, anxiety and pre-existing hypertension. Participants received Ashwagen®, a single proprietary standardised Withania somnifera extract, as a 300 mg capsule, or a placebo, twice daily (PMID 42105298). The authors report that Ashwagen® “significantly reduced anxiety and stress markers compared with placebo” (PMID 42105298). That result belongs to this one proprietary product and is not a finding for every ashwagandha preparation. Because the participants also had hypertension, the result describes that group.

Safety in an eight-week trial

A randomised, double-blinded, placebo-controlled study in 1,002 adults with stress and anxiety gave a root extract at 600 mg per day in two divided doses, or a placebo, for eight weeks (PMID 41943502). The authors report “No serious adverse events were reported” and a total of 74 adverse events (7.4%) (PMID 41943502).

Doses used in the trials

TrialDose as reportedSchedule and durationPMID
Randomised, placebo-controlled Phase III trial (one proprietary extract, Ashwagen®)300 mg capsuleTwice daily, 60 days42105298
Randomised, double-blinded, placebo-controlled safety study600 mg per day, in two divided doses8 weeks41943502

Capsule or oral liquid: what each form is

ConsiderationCapsuleOral liquid
What is preparedA capsule filled to the prescribed strengthAn oral liquid measured by volume
How the dose is setBy the number of capsules and the fillBy the measured volume
How it is takenSwallowed as a capsuleTaken by measure
What the prescription statesActive, strength per capsule, quantity and directionsActive, strength per measured volume, volume and directions

These descriptions of the two forms follow the way Lynnity prepares compounded capsules and oral liquids on a doctor’s prescription under Good Compounding Practice (GCP). The form and its specification are set by the prescriber for each named patient.

How to choose the form for a patient

Form choice is a prescriber decision for the named patient. The prescriber considers the patient’s ability to swallow a capsule and to measure a liquid, along with the dose the prescriber specifies. The cited trials do not compare the two forms, so the choice does not rest on a comparison of their results (PMID 36017529).

Patients in Kuala Lumpur and the Klang Valley who are prescribed a compounded form need a registered Malaysian doctor’s prescription, as set out in the guide to converting an overseas prescription.

How to get this prescribed

Ask your doctor to write the prescription for you as a named patient. It must state the active, ashwagandha extract, the strength, the form (capsule or oral liquid), the quantity and the directions. Your doctor then sends the prescription to Lynnity.

To contact the pharmacy, use the contact page. Preparation takes place in the compounding laboratory in Kuala Lumpur. The reviewing pharmacist is Vitthia Rama Murti, RPh (RPh 15632).

For related reading on form choice, see magnesium capsule or oral liquid and compounded saffron.

Reviewed by Vitthia Rama Murti, RPh (RPh 15632).

Frequently asked questions

Which form has the evidence behind it, a capsule or an oral liquid?

The cited evidence does not compare a capsule with an oral liquid, so neither form is shown to perform better (PMID 36017529). The choice rests on the prescriber’s assessment of the named patient and on the dose the prescriber specifies.

Does ashwagandha help with stress and anxiety?

A 2022 systematic review and meta-analysis of randomised trials reported a beneficial effect on stress and anxiety, but rated the certainty of the evidence as low (PMID 36017529). The authors state that further high-quality studies are needed to firmly establish clinical efficacy.

Is ashwagandha safe to take?

A 2026 eight-week randomised, double-blinded, placebo-controlled study in 1,002 adults with stress and anxiety reported no serious adverse events (PMID 41943502). The authors document a total of 74 adverse events (7.4%) (PMID 41943502), and tolerability ratings did not differ significantly between the groups.

What dose did the trials use?

The trials used different doses. One 60-day trial gave a single proprietary extract, Ashwagen®, as a 300 mg capsule twice daily, and its reported result belongs to that product (PMID 42105298). Another eight-week trial gave 600 mg per day in two divided doses (PMID 41943502). The strength for a named patient is set by the prescriber.

WhatsApp us